Early Treatment Failure in Patients With Relapsed/Refractory Multiple Myeloma Receiving Bispecifi...
November 14, 2026
Share
Early Treatment Failure in Patients With Relapsed/Refractory Multiple Myeloma Receiving Bispecific T-Cell Engagers: Development and Validation of the CHARGE Prognostic Index.